Europe also represents a major market for CIPN treatments due to increasing cancer diagnosis rates and the availability of advanced oncology care facilities. Additionally, favorable healthcare reimbursement policies support the adoption of neuropathy treatment therapies. The chemotherapy-induced peripheral neuropathy (CIPN) treatment market is gaining significant attention within the global...